Is a complete SHE/301507 research report available?

No complete published report is available for she/301507 (SHE/301507) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

she/301507 stock profile: metrics, valuation and analysis

Market cap	4.2B
Revenue (ttm)	854.5M
Net income (ttm)	119.8M
EPS (ttm)	CN¥0.33
Shares out	354.4M
P/E (trailing)	35.4x
Dividend	CN¥0.15 (1.22%)
Volume	2,348,720
Beta	0.53

All SHE/301507 indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

CNY

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	710
Enterprise value	CNY 3.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Industry PE	42.55
Isin	CNE1000068Q3
Last refreshed	2026-09-12
Market cap	CNY 4.2B
Price	CNY 11.72
Price currency	CNY
Sector	Healthcare
Sector PE	40
Sector PE Fwd	20.67
Sic	2834
Symbol	she/301507
Website	https://www.hzmsjk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.88%
EV Earnings	28.96x
EV/EBIT	34.07x
EV/EBITDA	26.57x
EV/Sales	4.06x
FCF yield	-0.21%
P/B ratio	2.4x
P/E ratio	35.43x
P/S ratio	4.86x
PE Ratio3 Y	52.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.91%
EBITDA Margin	15.17%
Gross margin	51.67%
Gross Profit	CNY 441.5M
Gross Profit Growth	20.51%
Gross Profit Growth Q	12.83%
Gross Profit Growth3 Y	26.8%
Gross Profit Growth5 Y	16.54%
Net Income	CNY 119.8M
Net Income Growth	23.52%
Net Income Growth Q	4.65%
Net Income Growth Qo Q	-67.16%
Net Income Growth3 Y	11.81%
Net Income Growth5 Y	29.2%
Pretax Margin	16.57%
Profit Margin	14.02%
ROA	3.12
Roa5y	4.39
ROCE	5.77
ROE	7.15
Roe5y	10.14
ROIC	9.62
Roic5y	15.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-16.93%
Cagr3y	-22.13%
EPS Growth	21.69
EPS Growth Q	2.16
EPS Growth Qo Q	-68.28
EPS Growth3 Y	2.09
OCF Growth	16.66%
OCF Growth Q	1.13%
OCF Growth Qo Q	-79.57%
OCF Growth3 Y	15.15%
OCF Growth5 Y	16.66%
Revenue Growth	20.98x
Revenue Growth Q	14.06x
Revenue Growth Qo Q	-31.38x
Revenue Growth3 Y	13.72x
Revenue Growth5 Y	22.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.42
Assets	CNY 2.1B
Cash	CNY 808.8M
Current Assets	CNY 1B
Current Liabilities	CNY 338.6M
Debt	CNY 2.7M
Debt EBITDA	CNY 0.02
Debt Equity	CNY 0
Debt FCF	CNY -0.31
Equity	CNY 1.7B
Interest Coverage	1,794.5
Liabilities	CNY 372M
Long Term Assets	CNY 1.1B
Long Term Liabilities	CNY 33.4M
Net Cash	CNY 806.1M
Net Cash By Market Cap	CNY 19.41
Net Cash Growth	-32.63%
Net Debt EBITDA	CNY -6.22
Net Debt Equity	CNY -0.47
Tangible Book Value	CNY 1.5B
Tangible Book Value Per Share	CNY 3.96
WACC	7.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.05
Inventory Turnover	6.07
Net Working Capital	CNY -111.7M
Quick ratio	2.59
Working Capital	CNY 695.2M
Working Capital Turnover	CNY 0.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.51%
Dividend Growth	50%
Dividend Growth Years	0%
Dividend per share	CNY 0.15
Dividend Years	3
Dividend Yield	1.22%
Ex Div Date	2026-06-09
Last Dividend	CNY 0.15
Payout Frequency	Annual
Payout Ratio	44.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-16.92%
200-day SMA	14.11
3Y total return	-52.79%
50-day SMA	12.46
50-day SMA vs 200-day SMA	50under200
All Time High	37.5
All Time High Change	-68.75%
All Time High Date	2023-09-05
All Time Low	10.28
All Time Low Change	14.01%
All Time Low Date	2024-02-06
ATR	0.41
Beta	0.53
Beta1y	0.25
Beta2y	0.39
Ch YTD	-23.7
High	11.97
High52	19.25
High52 Date	2025-11-14
High52ch	-39.12%
Low	11.62
Low52	11.4
Low52 Date	2026-07-27
Low52ch	2.81%
Ma50ch	-5.96%
Price vs 200-day SMA	-16.91%
RSI	36.31
RSI Monthly	35.71
RSI Weekly	37.68
Sharpe ratio	-0.55x
Sortino ratio	-0.62
Total Return	-0.29%
Tr YTD	-22.76
Tr1m	-8.22%
Tr1w	-5.79%
Tr3m	-3.86%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	108,409,858%
Net Borrowing	-1,501,016
Shares Institutions	3.25%
Shares Out	354,432,330
Shares Qo Q	3.53%
Shares Yo Y	1.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	4,163,616x
Bv Per Share	4.37
CAPEX	CNY -180.6M
Ch1m	-8.22
Ch1w	-5.79
Ch1y	-17.93
Ch3m	-3.86
Ch3y	-54.09
Ch6m	-21.29
Change	-2.58%
Change From Open	-1.92
Close	12.03
Days Gap	-0.67
Depreciation Amortization	27,777,039
Dollar Volume	27,526,998.4
Earnings Date	2026-08-28
EBIT	CNY 101.8M
EBITDA	CNY 129.6M
EPS	CNY 0.33
F Score	5
FCF	CNY -8.7M
FCF EV Yield	-0.25x
FCF Per Share	CNY -0.02
Financing CF	-73,281,845
Fiscal Year End	December
Founded	1,926
Goodwill	69,986,721
Graham Number	5.70206
Graham Upside	-51.35
Income Tax	CNY 19.5M
Investing CF	-152,609,451
Is Primary Listing	1
Last Earnings Date	2026-08-28
Last Report Date	2026-06-30
Lynch Fair Value	CNY 8.27
Lynch Upside	-29.44
Ma150	13.51
Ma150ch	-13.27%
Ma20	12.71
Ma20ch	-7.75%
Net CF	-53,928,880
Next Earnings Date	2026-10-28
Open	11.95
P OCF Ratio	24.16
Payment Date	2026-06-09
Position In Range	28.57
Ppne	569,602,420
Price Date	2026-09-11
Price EBITDA	CNY 32.05
Ptbv Ratio	2.84
Relative Volume	0.56x
Revenue	854,506,271x
Tax By Revenue	2.28x
Tax Rate	13.76%
Tr6m	-20.32%
Volume	2,348,720

SHE/301507 (SHE/301507)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/301507

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/301507 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SHE/301507

Frequently asked questions